HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer
Not yet recruiting
40 enrolled
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
Active not recruiting
2,907 enrolled
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
Completed
131 enrolled 8 charts
International Multicentric Study ARON-1
Recruiting
1,220 enrolled
STAR-T
Completed
818 enrolled
REFINE-IO
Recruiting
300 enrolled
HCC
Completed
166 enrolled
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
Terminated
2 enrolled
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
Active not recruiting
757 enrolled
DELINOR
Completed
5,279 enrolled 10 charts
CCGLC-001
Recruiting
300 enrolled
Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer
Not yet recruiting
200 enrolled
OVNI-B
Recruiting
300 enrolled
A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer
Not yet recruiting
200 enrolled
Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM
Recruiting
30 enrolled
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
Recruiting
15 enrolled
HCC
Unknown
100 enrolled
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma
Completed
188 enrolled
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Unknown
30 enrolled
COBRA
Unknown
121 enrolled
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
Completed
106 enrolled
Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer
Completed
90 enrolled
Microbiome Immunotherapy Toxicity and Response Evaluation
Unknown
1,800 enrolled
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
Completed
30 enrolled
a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors
Unknown
120 enrolled
An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)
Completed
3,003 enrolled
Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study
Not yet recruiting
100 enrolled
The Effects of Preoperative Bevacizumab on Perioperative Complications
Unknown
100 enrolled
BELLA
Unknown
272 enrolled
ROBOT
Unknown
300 enrolled
Argo
Completed
111 enrolled 14 charts
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
Completed
76 enrolled
Breast Cancer Treatment Based on Organ-like Culture
Unknown
300 enrolled
AVOCETTE
Unknown
2,000 enrolled
REBECA
Completed
50 enrolled
AVACONT
Completed
300 enrolled
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)
Completed
719 enrolled
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma
Completed
201 enrolled
A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
Completed
4,278 enrolled
CIRCUS
Completed
103 enrolled
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer
Unknown
15 enrolled
AVALANCHE
Completed
150 enrolled
Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
Completed
90 enrolled
Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel
Completed
180 enrolled
PICASSO
Completed
210 enrolled 22 charts
Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer
Terminated
11 enrolled
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer
Completed
68 enrolled 8 charts
Bevacizumab in Metastatic Renal Cancer
Completed
365 enrolled 9 charts
COBEQOL
Unknown
320 enrolled
Safety and Efficacy Study of Avastin in Locally Advanced Metastatic or Recurrent Non-small Lung Cancer (NSLC) Participants
Completed
996 enrolled 14 charts